) Specific brain regions, such as the nucleus accumbens and ventral tegmentum, are implicated in drug motivation. However, little is known about the role of these regions in human smoking motivation and relapse. This pilot study will recruit 10 smokers (5 male) to participate in 4 experimental functional magnetic resonance imaging (fMRI) assessment sessions. The sessions will manipulate both withdrawal status (24 hr withdrawal or ad lib smoking) and motivational state (neutral vs. anticipation of smoking). The results will reveal the extent to which incentive brain system structures such as the nucleus accumbens are influenced by manipulations of smoking motivation. In addition, smokers will receive nicotine replacement therapy (NRT-combined nicotine patch and nicotine nasal spray) prior to one of the sessions. This will indicate whether common smoking cessation treatments actually reduce activity of incentive system structures when smokers anticipate smoking. Finally, smokers will be exposed to non- pharmacologic incentive stimuli. This is one test of the notion that nicotine withdrawal reduces incentive system activity and thus, reduces pleasurable anticipation in response to non-drug incentives. These findings will make an important contribution to scientific understanding of the mechanisms of effective smoking cessation treatments and contribute to basic scientific understanding of motivation and addictive processes. Finally, they may provide clues to the vital clinical problem of preventing relapse following smoking cessation treatment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
3P50CA084724-04S1
Application #
6661430
Study Section
Special Emphasis Panel (ZCA1)
Project Start
2002-09-01
Project End
2003-08-31
Budget Start
Budget End
Support Year
4
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Guerreiro, Rita; Ross, Owen A; Kun-Rodrigues, Celia et al. (2018) Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study. Lancet Neurol 17:64-74
Glasheen, Cristie; Johnson, Eric O; Saccone, Nancy L et al. (2018) Is the Fagerström test for nicotine dependence invariant across secular trends in smoking? A question for cross-birth cohort analysis of nicotine dependence. Drug Alcohol Depend 185:127-132
Teitelbaum, A M; Murphy, S E; Akk, G et al. (2018) Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain. Pharmacogenomics J 18:136-143
Singh, Tarjinder; Walters, James T R; Johnstone, Mandy et al. (2017) The contribution of rare variants to risk of schizophrenia in individuals with and without intellectual disability. Nat Genet 49:1167-1173
Peckham-Gregory, Erin C; Chakraborty, Rikhia; Scheurer, Michael E et al. (2017) A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility. Blood 130:2229-2232
Taylor, Kimberly E; Wong, Quenna; Levine, David M et al. (2017) Genome-Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to Ancestry. Arthritis Rheumatol 69:1294-1305
Mercati, O; Huguet, G; Danckaert, A et al. (2017) CNTN6 mutations are risk factors for abnormal auditory sensory perception in autism spectrum disorders. Mol Psychiatry 22:625-633
Chen, Li-Shiun; Baker, Timothy; Brownson, Ross C et al. (2017) Smoking Cessation and Electronic Cigarettes in Community Mental Health Centers: Patient and Provider Perspectives. Community Ment Health J 53:695-702
Johnson, Eric O; Hancock, Dana B; Levy, Joshua L et al. (2016) KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. Addict Biol 21:1217-1232
Rees, Elliott; Kendall, Kimberley; Pardiñas, Antonio F et al. (2016) Analysis of Intellectual Disability Copy Number Variants for Association With Schizophrenia. JAMA Psychiatry 73:963-969

Showing the most recent 10 out of 86 publications